Nova Leap Health Corp. (TSXV:NLH)

Canada · Delayed Price · Currency is CAD

0.5900

+0.0300 (5.36%)

Aug 26, 2026, 11:31 AM EST

Nova Leap Health Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	33.6	31.47	25.76	26.18	28.21	21.28
Revenue Growth	19.53%	22.15%	-1.60%	-7.18%	32.55%	22.93%
Gross Profit	13.41	12.48	9.89	9.77	9.98	7.21
Operating Income	1.73	1.11	0.86	0.46	-1.06	-1.23
Net Income	1.35	-0.19	1.38	-1.05	-0.84	1.76
Earnings Per Share	0.02	-0.00	0.02	-0.01	-0.01	0.02
EPS Growth	1016.64%	-	-	-	-	3.67%

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	25.47	24.68	21.87	22.65	24.13	17.14
Canada	8.13	6.79	3.88	3.52	4.07	4.12
Group Head Office	-	0	0.01	0.01	0.01	0.01
Total	33.6	31.47	25.76	26.18	28.21	21.28

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1.44	1.49	1.4	0.89	1.27	1.73
Total Debt	4.45	2.93	2.53	1.4	3.97	6.2
Net Cash (Debt)	-3.01	-1.44	-1.12	-0.5	-2.69	-4.47
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.03	-0.02	-0.01	-0.01	-0.03	-0.06

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2.05	1.56	1.39	2.15	1.02	2.18
Capital Expenditures	-	-	-0.03	-0.03	-0.07	-
Free Cash Flow	2.05	1.56	1.36	2.13	0.95	2.18
Free Cash Flow Growth	45.53%	14.19%	-35.91%	123.97%	-56.44%	-27.47%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	39.92%	39.67%	38.38%	37.31%	35.37%	33.89%
Operating Margin	5.14%	3.52%	3.35%	1.76%	-3.77%	-5.79%
Pretax Margin	5.54%	-0.42%	7.03%	-5.22%	-4.28%	11.62%
Profit Margin	4.01%	-0.60%	5.35%	-4.03%	-2.96%	8.27%
FCF Margin	6.11%	4.95%	5.29%	8.12%	3.37%	10.24%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	27.64	-	11.89	-	-	21.71
Forward PE	-	18.95	18.95	6.05	6.16	16.07
P/FCF Ratio	18.10	11.46	12.02	9.21	16.77	17.53
PS Ratio	1.08	0.57	0.64	0.75	0.56	1.80